Table of Contents
Table of Contents
Preface
Chapter 1 – Cure of Thalassemia Major Using Related and Unrelated Donor Cord Blood Stem Cell Transplantation (pp. 1-36)
Lawrence D. Petz, M.D., John Chow, M.D., Ph.D., Tracie Dang, Andrew Song, Liang Liang, Michelle Chow, Christine Chow, Elizabeth Rao, Tang-Her Jaing, M.D. and Robert Chow, M.D., A.M. (StemCyte, Inc., Covina, California, USA, and others)
Chapter 2 – The Differential Diagnosis of Microcytosis (pp. 37-56)
Eloísa Urrechaga Igartua, Silvia Izquierdo Álvarez and Jesús Fernando Escanero Marcén (Laboratory. Hospital Galdakao – Usansolo, Galdakao, Vizcaya, Spain, and others)
Chapter 3 – Computer Aided Diagnosis of Thalassaemias: An Overview (pp. 57-70)
Giovanni Luca Masala and Bruno Golosio (POLCOMING Department, Section of Engineering and Information Technologies, University of Sassari, Viale Mancini, Sassari, Italy)
Chapter 4 – Hematopietic Stem Cell Transplantation for Thalassemia, Price and Prejudice (pp. 71-82)
Lawrence Faulkner, M.D. (Medical Coordinator Cure2Children Foundation, Florence, Italy)
Chapter 5 – Screening and Genotyping of Beta Thalassemia (pp. 83-122)
Sandra Stella Lazarte, María Eugenia Mónaco and Blanca Alicia Issé (Professor Cátedra Bioquímica Clínica I. Facultad de Bioquímica, Química y Farmacia. Universidad Nacional de Tucumán, Argentina, and others)
Chapter 6 – Molecular Therapies for Treatment of Thalassemia (pp. 123-134)
Eleni Papanikolaou (Laboratory of Biology, University of Athens School of Medicine, Athens, Greece)
Chapter 7 – Developments in the Molecular Diagnosis of Beta-Thalassaemia (pp. 135-154)
Sherry S. Y. Ho, Angela N. Barrett, Mahesh Choolani and Evelyn S. C. Koay (Departments of Laboratory Medicine, Molecular Diagnosis Centre, National University Hospital, Singapore, and others)
Chapter 8 Antioxidant Therapies for Thalassemia (pp. 155-174)
Ruchaneekorn W. Kalpravidh and Suneerat Hatairaktham (Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand)
Chapter 9 – Calcifications in Thalassemia: An Important Complication (pp. 175-178)
Somsri Wiwanitkit and Viroj Wiwanitkit (Wiwanitkit House, Bangkhae, Bangkok Thailand, and others)
Chapter 10 – Multi-Target Therapeutic Modalities for -Hemoglobinopathies (pp. 179-200)
Eitan Fibach (Department of Hematology, Hadassah – Hebrew University Medical Center, Jerusalem, Israel)
Chapter 11 – Assessing Services for Haemoglobin Disorders: A Toolkit for Service Planning (pp. 201-210)
Michael Angastiniotis and Androulla Eleftheriou (Thalassaemia International Federation, Nicosia, Cyprus)
Chapter 12 – Beta Thalasemia in Bahrain: An Overview (pp. 211-234)
Shaikha Al Arrayed (Chairperson of Genetic Department, Chairperson of Bahrain National Hereditary anemia Society, Genetic Department
Ministry of Health, Kingdom of Bahrain)
Chapter 13 – Dental and Orofacial Changes in Thalassemia Major: An Overview (pp. 235-248)
Faiez N. Hattab, B.D.S., Ph.D., Odont. Dr. (Amman, Jordan)
Index